Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease

NCT01969123 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

474

Enrollment

INDUSTRY

Sponsor class

Stopped Study has been suspended due to clinical hold.

Conditions

Alzheimer's Disease
Dementia

Interventions

DRUG: Drug: EVP-6124
DRUG: Placebo

Sponsor

FORUM Pharmaceuticals Inc